Premium
Commentary on “A Framework for Quantifying the Influence of Adherence and Dose Individualization”
Author(s) -
Urquhart J,
Vrijens B
Publication year - 2016
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.304
Subject(s) - action (physics) , drug , pharmacology , medicine , descriptive statistics , psychology , statistics , mathematics , quantum mechanics , physics
Drugs that provide long durations of action after a last‐taken dose are said to be “forgiving,” as they allow the patient a degree of latitude in the timing of sequential doses. New research, by Assawasuwannakit et al ., 1 based on exemplary methods, enriches the pharmacometric analysis of forgiveness, which for several decades had been a simply descriptive reminder that the beneficial actions of some drugs can continue for hours or days after the disappearance of detectable drug.